申请人:Parke, Davis & Company
公开号:US04055718A1
公开(公告)日:1977-10-25
9-(2-O-Acyl-.beta.-D-arabinofuranosyl)adenine compounds and their production by enzymatic removal of the 3-O-acyl and 5-O-acyl groups of a 9-(2,3-di-O-acyl-.beta.-D-arabinofuranosyl)adenine compound or a 9-(2,3,5-tri-O-acyl-.beta.-D-arabinofuranosyl)adenine compound. The monoester compounds are useful as antiviral agents. The compounds are watersoluble and lipophilic, thereby being adaptable to a wide variety of pharmaceutical formulations.
9-(2-O-Acyl-.beta.-D-arabinofuranosyl)腺嘌呤化合物及其通过酶法去除9-(2,3-二-O-酰基-.beta.-D-阿拉比呋喃糖苷)腺嘌呤化合物或9-(2,3,5-三-O-酰基-.beta.-D-阿拉比呋喃糖苷)腺嘌呤化合物的3-O-酰基和5-O-酰基而制备。这些单酯化合物可用作抗病毒剂。这些化合物具有水溶性和亲脂性,因此适用于各种药物制剂。